Cafepharma Daily Premium (On-Demand) Archive for April, 2019

Click a link below to view the mailing archive as if it had been sent to you.

2019-04-30 12:15Reports: Odds of Getting Drugs to Market Range from 6% to 40% and more...
2019-04-30 00:15In case around microbiome startup UBiome, FBI has heard allegations involving improper billing codes and physician relationships and more...
2019-04-29 12:15U.S. trust in pharma ticks upward, but consumers still distrust the industry: survey and more...
2019-04-29 00:15The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs and more...
2019-04-27 12:15How Smart Pharma Can Stop Making Bad R&D Choices and more...
2019-04-27 00:15Orphan drugs market to soar to $224bn by 2024 and more...
2019-04-26 12:15AstraZeneca dumps Amgen-partnered drug after midphase fail and more...
2019-04-26 00:15A decade of incentives to promote antibiotic development and still no viable route to commercial success and more...
2019-04-25 12:15GSK invests $100m to boost vaccine manufacturing at US facility and more...
2019-04-25 00:15Anthem Adds 900K Members As IngenioRx PBM Rollout Proceeds and more...
2019-04-24 14:20CP Microbiome Report
2019-04-24 12:15GenFit Moves Lead Candidate into Another Phase III Trial with Breakthrough Therapy and more...
2019-04-24 00:15In R&D, small biotechs hold their own against big pharma and more...
2019-04-23 12:15The biotech era in late-stage drug R&D and marketing has arrived. And it looks like it’s here to stay and more...
2019-04-23 00:15Ex-Theranos CEO Elizabeth Holmes to return to court in July to set possible trial date and more...
2019-04-22 12:15Merck Wins FDA Nod for Combo Therapy in Advanced Kidney Cancer and more...
2019-04-22 00:15Research Roundup: New CRISPR, ALS, Colon Cancer, Asthma and More and more...
2019-04-21 00:41CP Sat Premium: Infant death in Novartis study
2019-04-19 18:36CP Fri Evening Premium: Generic Naloxone spray approved
2019-04-19 12:45CP Fri Premium: Maine physician gift ban regulations strengthened
2019-04-18 22:42CP Thu Evening Premium: Looking ahead to AbbVie and BMS earnings
2019-04-18 12:49CP Thu Premium: Who got tops in pharma reputation survey?
2019-04-18 00:04CP Wed Evening Premium: Pharmas that own their markets
2019-04-17 13:35CP Wed Premium: New FDA chief vows to continue Gottlieb era
2019-04-16 23:46CP Tue Evening Premium: FDA halts pelvic mesh sales
2019-04-16 15:12CP Tue Premium: Positive data for Pfizer's 20-strain pneumococcal vaccine
2019-04-15 23:54CP Mon Evening Premium: Supreme Court sends Allergan packing
2019-04-15 13:20CP Mon Premium: Four new biotech IPOs
2019-04-15 00:06CP Sun Premium: JNJ's Invokana a winner against kidney disease?
2019-04-13 19:48CP Sat Premium: Upcoming events for Amgen and Cymabay
2019-04-12 23:59CP Fri Evening Premium: BMS-Celgene merger approved
2019-04-12 11:46CP Fri Premium: Keytruda now approved for first-line in NSCLC
2019-04-12 00:21CP Wed Evening Premium: M3 Biotechnologies rebrands
2019-04-11 14:32CP Thu Premium: Gilead's latest hope for NASH treatment
2019-04-10 23:49CP Wed Evening Premium: The insulin price Congressional hearing
2019-04-10 17:27CP Wed Premium: Sanofi to cut some insulin prices
2019-04-09 23:02CP Tue Evening Premium: How did PBMs fare on Capitol Hill?
2019-04-09 14:38CP Tue Premium: Novartis CEO has his checkbook out
2019-04-08 23:35CP Mon Evening Premium: Top 15 pharma by 2018 revenue
2019-04-08 13:25CP Mon Premium: PBM Executives to Face the Congressional Hot Seat This Week
2019-04-07 17:30CP Sun Premium: Healthcare in the age of personalization
2019-04-06 20:59CP Sat Premium: 10 CEOs Transforming Healthcare In America
2019-04-05 23:55CP Fri Evening Premium: How protestors said goodbye to Scott Gottlieb
2019-04-05 13:26CORRECTED: CP Fri Premium: Pfizer's Ibrance approved for breast cancer in men
2019-04-05 13:24CP Fri Premium: Pfizer's Ibrance approved for breast cancer in men
2019-04-04 23:30CP Thu Evening Premium: Should Biogen buy Ionis?
2019-04-04 14:32CP Thu Premium: Sanofi planning more layoffs
2019-04-03 23:23CP Wed Evening Premium: Key House lawmakers reach bipartisan deal on drug pricing bill
2019-04-03 13:54CP Wed Premium: AbbVie's Gonazlez faces growing criticism
2019-04-02 23:41CP Tue Evening Premium: JNJ Innovation in microbiome collaboration
2019-04-02 12:54CP Tue Premium: Another megafunding round for a radiopharmaceutical firm
2019-04-01 23:09CP Mon Evening Premium: Scott Gottlieb on leaving the FDA
2019-04-01 14:32CP Mon Premium: News from the AACR annual meeting

 

<< Archive IndexSubscribe >>

Contact Us

Past Issues

Unsubscribe